The group works on the design, synthesis, characterization and evaluation of lipid- and/or polymer-based nanostructured biomaterials. One specific interest lies in developing nanomaterials for healthcare and other medical applications, for example, drug delivery to improve or enable treatments of human diseases. In addition, we also seek to understand the fundamental sciences underlying the arenas of nanomedicine.
The group's overall research objective focuses on the development of hierarchically structured nanomaterials to study cell-cell interactions and the cooperative response of cells to extracellular matrixes.
The Master's of Science degree in NanoPharmacy is designed to train students in the skills they will need to understand the burgeoning technological advances in science at the nanoscale and how new nanomaterials and processes can be applied to drug delivery, diagnosis, treatment monitoring, tissue regeneration, personalized medicine and more. This program aims to bridge the gap between nanotechnology and medicine, providing students with advanced knowledge, skills and practical experience within the principles, technology and applications within this exciting and innovative area.
The NNRC is a university-wide user fabrication and metrology center providing state-of-the-art equipment, professional support personnel and infrastructure to enable multidisciplinary research in nanomaterials and nanomanufacturing methods related to fundamental materials science, sensors, actuators, electronics, bio-systems, medical products, optics and integrated nanoscale systems.
The Madhukar Group's research has revolved around electronic response (electrical and optical) of synthesized materials and structures in reduced (two, one, and zero) dimensions and their potential use in electronic and optoelectronic devices for information sensing, processing, imaging and computing technologies. The emphasis for some time has been on three dimensionally confined (i.e. zero dimensional) nanostructures called quantum dots and the scope in recent years has expanded to include biochemical materials (peptides, proteins) and hybrid semiconductor-biomolecular nanostructures for biomedical applications, particularly neural prostheses.
The group's mission is to develop novel semiconductor materials and devices to address a few issues facing today's semiconductor industry, and more generally, our society. Research focuses on semiconductor surfaces, interfaces, and thin films.